These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20874654)

  • 21. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on mechanisms of allergen injection immunotherapy.
    James LK; Durham SR
    Clin Exp Allergy; 2008 Jul; 38(7):1074-88. PubMed ID: 18691292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.
    Virkud YV; Wang J; Shreffler WG
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):172-189. PubMed ID: 29968170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization.
    Tumas DB; Chan B; Werther W; Wrin T; Vennari J; Desjardin N; Shields RL; Jardieu P
    J Allergy Clin Immunol; 2001 Jun; 107(6):1025-33. PubMed ID: 11398080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Future perspectives in the therapy of asthma in children].
    Tosca MA; Villa E; Rossi GA
    Minerva Pediatr; 2008 Apr; 60(2):235-47. PubMed ID: 18449140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy as a disease modifier.
    Martin JG; Shalaby K; Michoud MC
    Paediatr Respir Rev; 2006; 7 Suppl 1():S106-7. PubMed ID: 16798526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual cytokines contributing to asthma pathophysiology: valid targets for asthma therapy?
    Chung KF
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1320-6. PubMed ID: 14758771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model.
    Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS
    Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of anticytokine therapy in a mouse model of chronic asthma.
    Kumar RK; Herbert C; Webb DC; Li L; Foster PS
    Am J Respir Crit Care Med; 2004 Nov; 170(10):1043-8. PubMed ID: 15306533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
    J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.
    Razafindratsita A; Saint-Lu N; Mascarell L; Berjont N; Bardon T; Betbeder D; Van Overtvelt L; Moingeon P
    J Allergy Clin Immunol; 2007 Aug; 120(2):278-85. PubMed ID: 17531296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future forms of immunotherapy and immunomodulators in allergic disease.
    Nguyen TH; Stokes JR; Casale TB
    Immunol Allergy Clin North Am; 2011 May; 31(2):343-65, x-xi. PubMed ID: 21530824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in mechanisms of asthma, allergy, and immunology in 2011.
    Boyce JA; Bochner B; Finkelman FD; Rothenberg ME
    J Allergy Clin Immunol; 2012 Feb; 129(2):335-41. PubMed ID: 22284930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T regulatory cells in childhood asthma.
    Strickland DH; Holt PG
    Trends Immunol; 2011 Sep; 32(9):420-7. PubMed ID: 21798806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Failure of allergen-based immunotherapy in adults with allergic asthma].
    Reyes Moreno A; Castrejón Vázquez MI; Miranda Feria AJ
    Rev Alerg Mex; 2003; 50(1):8-12. PubMed ID: 12822542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-IgE therapy in asthma: rationale and therapeutic potential.
    Barnes PJ
    Int Arch Allergy Immunol; 2000 Nov; 123(3):196-204. PubMed ID: 11112855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of bronchial inflammation: chemoreceptors as therapeutic targets.
    Marshall GD
    Allergy Asthma Proc; 2000; 21(5):309-13. PubMed ID: 11061042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.